Diabetes mellitus and electrolyte disorders.
暂无分享,去创建一个
[1] Susan E. Spratt,et al. The Implementation and Evaluation of an Evidence-Based Protocol to Treat Diabetic Ketoacidosis: A Quality Improvement Study , 2014, Advanced emergency nursing journal.
[2] M. Elisaf,et al. Effects of glucagon-like peptide-1 receptor agonists on renal function. , 2013, World journal of diabetes.
[3] L. Tarnow,et al. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial , 2013, Journal of hypertension.
[4] D. Kohan,et al. Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control , 2013, Kidney international.
[5] F. Barkas,et al. Spurious Electrolyte Disorders: A Diagnostic Challenge for Clinicians , 2013, American Journal of Nephrology.
[6] G. Funk,et al. Hypernatremia in critically ill patients. , 2013, Journal of critical care.
[7] N. Wright,et al. Severe Hypercalcemia in Diabetic Ketoacidosis: A Case Report , 2013, Diabetes Care.
[8] A. Hofman,et al. Electrolyte disorders in community subjects: prevalence and risk factors. , 2013, The American journal of medicine.
[9] G. Alexandridis,et al. Hypomagnesemia in a department of internal medicine. , 2012, Magnesium research.
[10] M. Hegazi,et al. Central Pontine Myelinolysis in the Hyperosmolar Hyperglycaemic State , 2012, Medical Principles and Practice.
[11] H. Rakugi,et al. Hypomagnesemia in Type 2 Diabetic Nephropathy , 2012, Diabetes Care.
[12] B. Epstein,et al. Dapagliflozin: A Novel Sodium‐Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus , 2012, Pharmacotherapy.
[13] H. Milionis,et al. Hyponatremia in patients with infectious diseases. , 2011, The Journal of infection.
[14] K. He,et al. Magnesium Intake and Risk of Type 2 Diabetes , 2011, Diabetes Care.
[15] L. Palmer,et al. Magnesium modulates ROMK channel-mediated potassium secretion. , 2010, Journal of the American Society of Nephrology : JASN.
[16] C. Kesavadas,et al. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[17] H. Milionis,et al. Medication-induced hypophosphatemia: a review. , 2010, QJM : monthly journal of the Association of Physicians.
[18] M. Raebel,et al. Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring , 2010, Journal of General Internal Medicine.
[19] L. V. Van Gaal,et al. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. , 2009, The Netherlands journal of medicine.
[20] A. Svare. A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report , 2009, Cases journal.
[21] H. Milionis,et al. A review of drug-induced hypocalcemia , 2009, Journal of Bone and Mineral Metabolism.
[22] J. N. Fisher,et al. Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.
[23] T. Erbas,et al. Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma , 2009, Endocrine.
[24] Tae-Jin Park,et al. Magnesium Metabolism , 2008, Electrolyte & blood pressure : E & BP.
[25] D. Berker,et al. Severe hyponatremia due to rosiglitazone use in an elderly woman with diabetes mellitus: a rare cause of syndrome of inappropriate antidiuretic hormone secretion. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[26] J. Kouba,et al. Vitamin D and Diabetes , 2008, The Diabetes educator.
[27] H. Milionis,et al. Blood pressure drug therapy and electrolyte disturbances , 2008, International journal of clinical practice.
[28] H. Milionis,et al. A review of drug-induced hyponatremia. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] S. Moe. Disorders involving calcium, phosphorus, and magnesium. , 2008, Primary care.
[30] J. Lado-Abeal,et al. Hyperglycaemic Hyperosmolar Nonketotic State as a Cause of Low Gonadotrophin Levels in Postmenopausal Diabetic Women: A Role for Severe Hypernatraemia , 2007, Journal of neuroendocrinology.
[31] M. Elisaf,et al. Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] A. Kitabchi,et al. Hyperglycemic Crises in Adult Patients With Diabetes: A Consensus Statement From the American Diabetes Association , 2007, Diabetes Care.
[33] R. Zietse,et al. Novel risk factors for hospital‐acquired hyponatraemia: a matched case–control study , 2007, Clinical endocrinology.
[34] Jeffrey M. Miller,et al. Hypomagnesemia in patients with type 2 diabetes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[35] M. Barbagallo,et al. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. , 2007, Archives of biochemistry and biophysics.
[36] M. Elisaf,et al. Therapeutic approach in patients with dysnatraemias. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] A. Topaloğlu,et al. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion. , 2005, Bone.
[38] J. Miller,et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. , 2005, Clinical nephrology.
[39] Haruo Nishimura,et al. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. , 2005, Diabetes research and clinical practice.
[40] R. S. Smith,et al. A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. , 2005, American journal of surgery.
[41] A. Chibalin,et al. Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. , 2005, American journal of physiology. Renal physiology.
[42] B. Palmer. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. , 2004, The New England journal of medicine.
[43] G. Borretta,et al. Derangement of glucose metabolism in hyperparathyroidism , 2003, Journal of endocrinological investigation.
[44] J. Chiasson,et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[45] W. H. Taylor,et al. Coincident diabetes mellitus and primary hyperparathyroidism , 2001, Diabetes/metabolism research and reviews.
[46] H. Milionis,et al. Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndrome , 2001, Journal of internal medicine.
[47] L. Bankir,et al. Vasopressin and Diabetes mellitus , 2001, Nephron.
[48] M. Elisaf,et al. Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment? , 2000, Diabetes & metabolism.
[49] D. Cucinotta,et al. Serum Ionized Magnesium Levels in Type 2 Diabetic Patients with Microalbuminuria or Clinical Proteinuria , 2000, American Journal of Nephrology.
[50] C. Wilcox,et al. Metabolic and adverse effects of diuretics. , 1999, Seminars in nephrology.
[51] R. Abbott,et al. Hyponatremia: evaluating the correction factor for hyperglycemia. , 1999, The American journal of medicine.
[52] P. Schuck,et al. Magnesium and phosphorus , 1998, The Lancet.
[53] J. Bauza,et al. Reliability of serum magnesium values during diabetic ketoacidosis in children. , 1998, Boletin de la Asociacion Medica de Puerto Rico.
[54] T. Berl,et al. The hyponatremic patient: practical focus on therapy. , 1997, Journal of the American Society of Nephrology : JASN.
[55] K. Siamopoulos,et al. Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. , 1996, Diabetes research and clinical practice.
[56] A. Kolasa,et al. Regulation of the insulin-like growth factor system by acute acidosis. , 1996, Endocrinology.
[57] Graham M Lord,et al. Diabetes and rhabdomyolysis. A rare complication of a common disease. , 1993, BMJ.
[58] P. Mcnair,et al. Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. , 1992, Acta endocrinologica.
[59] J. Daugirdas,et al. Asymptomatic, nonketotic, severe hyperglycemia with hyponatremia. , 1990, Archives of internal medicine.
[60] A. Arieff,et al. Fatal central diabetes mellitus and insipidus resulting from untreated hyponatremia: a new syndrome. , 1990, Annals of internal medicine.
[61] W. Waldhäusl,et al. Effect of hyperosmolality on basal and hormone‐stimulated hepatic glucose metabolism in vitro , 1989, European journal of clinical investigation.
[62] W. Waldhäusl,et al. Detrimental effect of hyperosmolality on insulin-stimulated glucose metabolism in adipose and muscle tissue in vitro. , 1988, Biochemical medicine and metabolic biology.
[63] G. Paolisso,et al. Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man , 1986, Diabetologia.
[64] G. Eknoyan,et al. Determinants of Plasma Potassium Levels in Diabetic Ketoacidosis , 1986, Medicine.
[65] P. Cadnapaphornchai,et al. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. , 1985, The American journal of medicine.
[66] M H Kroll,et al. Relationships between magnesium and protein concentrations in serum. , 1985, Clinical chemistry.
[67] R. DeFronzo,et al. Impairment of Insulin-mediated Glucose Metabolism by Hyperosmolality in Man , 1983, Diabetes.
[68] T. Kadowaki,et al. Chlorpropamide-induced Hyponatremia: Incidence and Risk Factors , 1983, Diabetes Care.
[69] A. Kitabchi,et al. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. , 1983, The Journal of clinical endocrinology and metabolism.
[70] L. Kerp,et al. Regulation of Serum Potassium During Insulin-induced Hypoglycemia , 1982, Diabetes.
[71] K. Minaker,et al. Potassium homeostasis during hyperinsulinemia: effect of insulin level, beta-blockade, and age. , 1982, The American journal of physiology.
[72] G. Eknoyan,et al. Phosphate therapy in diabetic ketoacidosis. , 1982, Archives of internal medicine.
[73] N. Madias,et al. Changes in plasma potassium concentration during acute acid-base disturbances. , 1981, The American journal of medicine.
[74] U. Keller,et al. Prevention of Hypophosphatemia by Phosphate Infusion During Treatment of Diabetic Ketoacidosis and Hyperosmolar Coma , 1980, Diabetes.
[75] L. Phillips,et al. Diabetic ketoacidosis: Induction of hypocalcemia and hypomagnesemia by phosphate therapy , 1979 .
[76] H Lund-Andersen,et al. Transport of glucose from blood to brain. , 1979, Physiological reviews.
[77] R. Kreisberg,et al. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. , 1978, Annals of internal medicine.
[78] R. Kreisberg,et al. Phosphorus deficiency and hypophosphatemia. , 1977, Hospital practice.
[79] A. Moses,et al. Diuretic action of three sulfonylurea drugs. , 1973, Annals of internal medicine.
[80] P. Beigelman. Potassium in severe diabetic ketoacidosis. , 1973, The American journal of medicine.
[81] C. Boitard,et al. Hyperparathyroidism in a patient with autoimmune polyglandular syndrome. , 2008, Internal medicine.
[82] E. Balint,et al. Glucose-induced inhibition of in vitro bone mineralization. , 2001, Bone.
[83] M. Matsumura,et al. Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. , 2000, Internal medicine.
[84] P. Singhal,et al. Determinants of rhabdomyolysis in the diabetic state. , 1991, American journal of nephrology.
[85] J. Uribarri,et al. Hyperkalemia in diabetes mellitus. , 1990, The Journal of diabetic complications.
[86] E. Heidbreder,et al. Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia. , 1986, Nephron.
[87] D. Batlle,et al. Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone. , 1981, American journal of nephrology.
[88] F. B. Davis,et al. Water metabolism in diabetes mellitus. , 1981, The American journal of medicine.
[89] C. Christiansen,et al. Hypoparathyroidism in diabetes mellitus. , 1981, Acta endocrinologica.
[90] R. DeFronzo,et al. Hyperkalemia and hyporeninemic hypoaldosteronism. , 1980, Kidney international.
[91] A. Mehta,et al. Pathogenesis and treatment , 2022 .